1Millionbot, the company that offers the most effective service in conversational chatbots by guaranteeing a 90%+ percentage of correct answers, has successfully closed a €1.5M funding round, bringing its total value to €8.5M.
Chatbots and intelligent virtual assistants act with the user through text or voice, but always based on artificial intelligence. Despite being a recent creation, this company has managed to develop them in very diverse sectors and has recognised complex success stories, such as the chatbot for enrolment at some universities, or the citizen service chatbot for local councils and public administrations..
This Start Up is the only company with four very different technological developments according to different typologies and objectives: Marketing and Online Commerce, Customer Acquisition, Call Centre and Internal Communication, and has recently managed to raise 1,5M€.
It is a round atypical, as investors are customers or come from sectors where Artificial Intelligence or intelligent virtual assistants have a greater future perspective, such as banking, health or insurance, for example. In this way, fruitful and advantageous relationships can be established with leading companies in key sectors.
This capital increase will aim to expand two new lines of work: on the one hand, strengthen the marketing process of the company's products, as well as its internationalisation.and, on the other hand, developing new technology for artificial intelligence.
In addition, 1MillionBot connects to market-leading databases and CRMs.
Sherpa, Spanish start up recognised as one of the 100 most innovative companies in the world of artificial intelligence by the US consulting company CB Insightshas recently closed a financing round of 8,5M$The aim is to accelerate its growth and create a commercial structure.
Investors include the fund mundi Venturesbased in Madrid, London and Seattle, several Business Angels as President and CEO of British Airways, Alex Cruz, or the Basque background Orza.
With this amount, the company now accumulates 15M$ in Series A funding.
Mediktor is a symptom evaluator managed to lift 3M€ in its latest round of funding, an amount that will help it with its plans to commercialise its artificial intelligence application in the North American market.
This monetary injection has been led by Alta Life Sciences. But they also include Castel Capital and the French company Naos, as well as other minority partners.